The Impact of A Web-Based Lifestyle Educational Program (‘Living Better’) Reintervention on Hypertensive Overweight or Obese Patients During The COVID-19 Pandemic.
Abstract ‘Living Better’, a self-administered web-based intervention, designed to facilitate lifestyle changes, has already shown positive short and medium-term health benefits in patients with an obesity-hypertension phenotype. The objectives of this study were: (1) to examine the long-term (3-year) evolution of a group of hypertensive overweight or obese patients who had already followed the ‘Living Better’ program; (2) to analyse the effects of completing this program a second time (reintervention) during the COVID-19 pandemic. A quasi-experimental uncontrolled design was used. We recruited 29 individuals from the 105 who had participated in our first study. We assessed and compared their systolic and diastolic blood pressure (SBP and DBP, respectively), Body Mass Index (BMI), eating behavior, and physical activity levels (METs-min/week) at Time 0 (follow-up 12 months after the first intervention), Time 1 (before the reintervention), and Time 2 (post-reintervention). Our results showed significant improvements between Time 1 and Time 2 in terms of SBP [−4.7 (−8.7 to −0.7); P=.017], DBP [−3.5 (−6.2 to −0.8); P=.009], BMI [−0.7 (−1.0 to −0.4); P<.001], emotional eating [−2.8 (−5.1 to −0.5); P=.012], external eating [−1.1 (−2.1 to −0.1); P=.039], and physical activity levels (Time 1: 2308±2266; Time 2: 3203±3314; P=.030, Z=-2,17). Statistical analysis showed no significant differences in SPB, DBP, BMI, and eating behavior between Time 0 and Time 1 (P>.24). Implementation of the ‘Living Better’ program maintained some positive long-term (3-year) health benefits in patients with an obesity-hypertension phenotype. Moreover, a reintervention with this same program during the ongoing COVID-19 pandemic produced significant improvements in blood pressure, BMI, eating behavior, and physical activity levels beyond the 3-year follow-up.Trial Registration: ClinicalTrials.gov NCT04571450; https://clinicaltrials.gov/ct2/show/NCT04571450; First Posted: 01/10/2020.